• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Shared decision making for prostate cancer screening: do patients or clinicians have a choice?

作者信息

Woolf Steven H, Krist Alex

出版信息

Arch Intern Med. 2009 Sep 28;169(17):1557-9. doi: 10.1001/archinternmed.2009.291.

DOI:10.1001/archinternmed.2009.291
PMID:19786673
Abstract
摘要

相似文献

1
Shared decision making for prostate cancer screening: do patients or clinicians have a choice?前列腺癌筛查的共同决策：患者还是临床医生有选择权？
Arch Intern Med. 2009 Sep 28;169(17):1557-9. doi: 10.1001/archinternmed.2009.291.
2
To screen or not to screen? Prostate cancer screening: why it's not for every man.筛查还是不筛查？前列腺癌筛查：为何并非适用于每个男性。
Medscape J Med. 2008;10(8):181. Epub 2008 Aug 3.
3
Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).前列腺癌筛查决策：全国医疗决策调查（DECISIONS研究）结果
Arch Intern Med. 2009 Sep 28;169(17):1611-8. doi: 10.1001/archinternmed.2009.262.
4
Unwanted control: how patients in the primary care setting decide about screening for prostate cancer.非意愿性控制：基层医疗环境中的患者如何决定是否进行前列腺癌筛查。
Patient Educ Couns. 2005 Jan;56(1):116-24. doi: 10.1016/j.pec.2003.12.002.
5
A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.低风险至高风险男性前列腺特异性抗原筛查结果模型：支持明智选择的信息
Arch Intern Med. 2009 Sep 28;169(17):1603-10. doi: 10.1001/archinternmed.2009.282.
6
New prostate cancer screening guidelines.新的前列腺癌筛查指南。
J Am Osteopath Assoc. 1993 Jul;93(7):736.
7
Prostate cancer screening: should family physicians discuss it with their patients?前列腺癌筛查：家庭医生应与患者讨论此事吗？
Can Fam Physician. 2000 Dec;46:2384-5.
8
Weighing the benefits and downsides of prostate-specific antigen screening.权衡前列腺特异性抗原筛查的利弊。
Arch Intern Med. 2009 Sep 28;169(17):1554-6. doi: 10.1001/archinternmed.2009.269.
9
Moving towards shared decision making in prostate cancer screening.迈向前列腺癌筛查中的共同决策
J Gen Intern Med. 2007 Jul;22(7):1056-7. doi: 10.1007/s11606-007-0167-7.
10
Counseling patients about prostate cancer screening.就前列腺癌筛查向患者提供咨询。
Am Fam Physician. 2002 May 1;65(9):1752, 1754, 1757.

引用本文的文献

1
Prostate-Specific Antigen Screening According to Health Professional Counseling and Age in the United States.美国基于健康专业人士咨询和年龄的前列腺特异性抗原筛查
Prostate Cancer. 2022 Jan 6;2022:8646314. doi: 10.1155/2022/8646314. eCollection 2022.
2
How should prostate specific antigen be interpreted?前列腺特异性抗原应如何解读？
Turk J Urol. 2013 Sep;39(3):188-93. doi: 10.5152/tud.2013.038.
3
PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making.基于 PSA 的前列腺癌筛查：主动监测的作用以及知情和共同决策。
Asian J Androl. 2011 Mar;13(2):219-24. doi: 10.1038/aja.2010.180. Epub 2011 Feb 7.
4
Perineal discomfort in prostatic adenocarcinoma.前列腺腺癌中的会阴部不适
JRSM Short Rep. 2010 Oct 1;1(5):38. doi: 10.1258/shorts.2010.010047.
5
Helping men make an informed decision about prostate cancer screening: a pilot study of telephone counseling.帮助男性做出关于前列腺癌筛查的知情决策：电话咨询的试点研究。
Patient Educ Couns. 2011 Feb;82(2):193-200. doi: 10.1016/j.pec.2010.05.011. Epub 2010 Jun 15.